Compound Q&A
What is the market or research trend for Mast Cell Degranulating (MCD) Peptide HR-2 (CAS: 80388-04-1)?
Answer
The market and research trend for Mast Cell Degranulating (MCD) Peptide HR-2 (CAS: 80388-04-1) is growing due to its potential in the treatment of allergic and inflammatory diseases. Research is focusing on its therapeutic applications and developing similar peptides with enhanced efficacy and reduced side effects. Demand is increasing as more studies validate its biological activities and safety profile.
About
CAS No
80388-04-1
English Name
Mast Cell Degranulating (MCD) Peptide HR-2 H-Phe-Leu-Pro-Leu-Ile-Leu-Gly-Lys-Leu-Val-Lys-Gly-Leu-Leu-NH2
Molecular Formula
C77H135N17O14
Molecular Weight
1523 g/mol
SMILES
CCC(C)C(C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)N)NC(=O)C(CC(C)C)NC(=O)C1CCCN1C(=O)C(CC(C)C)NC(=O)C(CC2=CC=CC=C2)N
InChIKey
XLTWUWYATXRNPA-KXQPRXDCSA-N
Last Updated: 2026-03-18 05:47
